An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial
Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial
Valneva withdraws application for standard US approval of its chikungunya shot
Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings
Valneva Shares Rise on Positive Data from Lyme Disease Vaccine Study
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
Safety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In US
FDA suspends Valneva's chikungunya vaccine license in the U.S.
Europe lifts restriction on Valneva's chikungunya vaccine for elderly adults
UK's MHRA suspends Valneva's chikungunya vaccine for elderly
Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people
Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot
Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine
EU regulator recommends use of Valneva's chikungunya vaccine
French biotech company Valneva raises product sales guidance
Valneva sells chikungunya vaccine priority review voucher for $103 mln
Valneva says EU regulator accepts its chikungunya vaccine application
FDA approves Valneva's Chikungunya vaccine for adults
US FDA approves Valneva's chikungunya vaccine
Pfizer, Valneva announce 'positive' results for Lyme disease vaccine candidate booster shot